YungShin Global Holding CoTPE:3705 90 Net Margin % is 12.32% as of Dec. 2025, which is 21% above its 10-year median of 10.16. GuruFocus rates TPE:3705 with a GF Score™ of 90/100 and a GF Value™ of NT$58.20 (Fairly Valued). The stock has 3 warning signs investors should review. Among 957 Drug Manufacturers companies, YungShin Global Holding Co ranks better than 65.94% on this metric.
The historical rank and industry rank for YungShin Global Holding Co's Net Margin % or its related term are showing as below:
TPE:3705'
s Net Margin % Range Over the Past 10 Years
Min: 7.76 Med: 10.16 Max: 14.55
Current: 10.52
TPE:3705's Net Margin % is ranked better than 65.94% of 957
companies
in the Drug Manufacturers industry
Industry Median: 5.58
vs TPE:3705: 10.52
YungShin Global Holding Co (TPE:3705) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
YungShin Global Holding Co Net Margin % Related Terms
YungShin Global Holding Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, YungShin Global Holding Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
YungShin Global Holding Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, YungShin Global Holding Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where YungShin Global Holding Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YungShin Global Holding Co (TPE:3705) has a Net Margin % of 12.32% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on YungShin Global Holding Co and its competitors. This is 21% above median its historical median of 10.16. Over the past decade, YungShin Global Holding Co's Net Margin % has ranged from 7.76 to 14.55. According to the industry distribution chart, YungShin Global Holding Co ranks #326 out of 957 companies in the Drug Manufacturers industry, placing it in the top 34.1%.
Is YungShin Global Holding Co's Net Margin % too high?
YungShin Global Holding Co's current Net Margin % of 12.32% is 21% above median its 10-year median of 10.16. Over the past 10 years, this metric has ranged from a low of 7.76 to a high of 14.55. The Drug Manufacturers industry median Net Margin % is 5.58. YungShin Global Holding Co's value of 12.32% is 120.8% above this industry median. Based on the distribution chart, YungShin Global Holding Co ranks #326 out of 957 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, YungShin Global Holding Co has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does YungShin Global Holding Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, YungShin Global Holding Co ranks #326 out of 957 companies for Net Margin %. This puts YungShin Global Holding Co in the upper half of its industry. The industry median Net Margin % is 5.58. YungShin Global Holding Co's value of 12.32% is 120.8% above this benchmark. Historically, YungShin Global Holding Co's own Net Margin % has ranged from 7.76 to 14.55 over the past decade. While the company's 10-year median is 10.16 vs. the industry median of 5.58, YungShin Global Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.58, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. YungShin Global Holding Co's current Net Margin % of 12.32% is 120.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on YungShin Global Holding Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. YungShin Global Holding Co's current Net Margin % is 12.32%, which is 21% above median its own 10-year median of 10.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YungShin Global Holding Co stock overvalued right now?
Based on GuruFocus' analysis, YungShin Global Holding Co (TPE:3705) is currently considered Fairly Valued. The stock's GF Value™ is NT$58.20, compared to a current price of NT$54.60 — trading 6.2% below its estimated fair value. The current Net Margin % is 12.32%, which is 21% above median its 10-year median of 10.16 and 120.8% above the Drug Manufacturers industry median of 5.58. YungShin Global Holding Co's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For YungShin Global Holding Co (TPE:3705), the current Net Margin % is 12.32% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is YungShin Global Holding Co (TPE:3705) Overvalued in 2026?
Based on GuruFocus' analysis, YungShin Global Holding Co stock appears to be undervalued.
The current stock price of NT$54.60 is trading 6.2% below its estimated GF Value™ of NT$58.20.
GuruFocus considers YungShin Global Holding Co to be Fairly Valued.
Key valuation signals for TPE:3705:
Net Margin %: 12.32% (21% above median its 10-year median of 10.16)
GF Value™: NT$58.20 vs. price of NT$54.60 (6.2% below fair value)
Industry Position: 120.8% above the Drug Manufacturers median (#326 of 957)
No single metric tells the full story. See the TPE:3705 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
YungShin Global Holding Co Ltd invests, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics. The company derives revenue from the sale of Human drugs, Health food, Animal drugs, and Others. The company generates the majority of its revenue from Human drugs. Geographically, the company generates the revenue from Taiwan, the USA, Japan, and China, out of which the majority of its revenue is generated from Taiwan.
90GF Score
Get the complete analysis for TPE:3705
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3705 has been successfully added to your 
